
BenevolentAI
None

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.
For Tasks:
Click tags to check more tools for each tasksFor Jobs:
Features
- AI-enabled drug discovery
- End-to-end drug discovery offerings
- Preclinical & clinical development pipeline
- New Knowledge Exploration tools
- Multi-year collaboration with AstraZeneca
Advantages
- Accelerate drug discovery
- Improve the probability of clinical success
- Deliver life-changing treatments to patients
- Provide a multidimensional representation of human biology across all diseases
- Enable scientists to make higher-confidence decisions and improve discovery and research productivity
Disadvantages
- High cost
- Requires a lot of data
- Can be difficult to interpret the results
Frequently Asked Questions
-
Q:What is BenevolentAI?
A:BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. -
Q:What is the Benevolent Platform™?
A:The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. -
Q:What are the benefits of using BenevolentAI?
A:BenevolentAI can accelerate drug discovery, improve the probability of clinical success, and deliver life-changing treatments to patients.
Alternative AI tools for BenevolentAI
Similar sites

BenevolentAI
BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

AnswerTime
AnswerTime is an AI-led research tool that leverages artificial intelligence to provide quick and accurate answers to a wide range of research questions. The platform is designed to assist users in finding relevant information efficiently, saving time and effort in the research process. AnswerTime utilizes advanced algorithms to analyze and process data from various sources, delivering reliable results in a matter of seconds. With its user-friendly interface and powerful AI capabilities, AnswerTime is a valuable tool for students, professionals, and researchers seeking to enhance their research productivity.

txyz.ai
txyz.ai is an AI-powered platform that aims to integrate all paths to knowledge. It leverages artificial intelligence algorithms to provide users with a comprehensive and efficient way to access and organize information. The platform offers a user-friendly interface that allows individuals to streamline their research process, gather insights, and make data-driven decisions. With txyz.ai, users can explore diverse sources of information, extract valuable insights, and stay updated on the latest trends in their field of interest.

Personno.ai
Personno.ai is an AI-driven market research platform that provides businesses with access to a pool of AI-generated respondents. These respondents are designed to mimic the behavior and characteristics of real human respondents, allowing businesses to conduct research studies quickly and cost-effectively. Personno.ai's platform includes a range of features that make it easy to create and manage research studies, including the ability to create custom audiences, conduct real-time interviews, and collect both qualitative and quantitative data.

Blobfish AI
Blobfish AI is an innovative artificial intelligence tool that leverages advanced algorithms to analyze and interpret complex data sets. It offers a user-friendly interface for users to input data and receive valuable insights and predictions. The tool is designed to assist businesses in making informed decisions, optimizing processes, and gaining a competitive edge in their respective industries. With Blobfish AI, users can harness the power of AI technology without the need for extensive technical knowledge, making it accessible to a wide range of users.

Holler
Holler is an AI-powered survey tool that helps businesses collect feedback and gain insights from their customers. It is designed to be simple and easy to use, with a variety of features that make it a powerful tool for businesses of all sizes. Holler can be used to collect feedback on a variety of topics, including customer satisfaction, product development, and employee engagement. The AI-powered insights engine can help businesses identify trends and patterns in the data, and make recommendations for how to improve their products and services.

Prefit.AI
Prefit.AI is a generative AI search engine that enables users to quickly generate new content based on a variety of inputs. It can explore and analyze complex data in new ways, discover new trends and patterns, and summarize content, outline multiple solution paths, brainstorm ideas, and create detailed documentation from research notes. Prefit.AI can also respond naturally to human conversation and serve as a tool for customer service and personalization of customer workflows. It can augment employee workflows and act as efficient assistants for everyone in your organization.

MapsScraperAI
MapsScraperAI is an AI-powered tool designed to extract leads and data from Maps. It offers businesses the ability to generate local B2B leads, conduct research, monitor competition, and obtain business contact details. With features like batch lookup, lightning-fast results, and the unique ability to extract email addresses, MapsScraperAI streamlines the process of data extraction without the need for coding. The tool mimics real user behavior to reduce the risk of being blocked by Maps and ensures timely updates to accommodate any changes on the Maps website.

GizAI
GizAI is an advanced artificial intelligence tool designed to streamline and optimize various tasks across different industries. With cutting-edge machine learning algorithms, GizAI offers a wide range of features to enhance productivity and decision-making processes. From data analysis to predictive modeling, GizAI empowers users with actionable insights and automation capabilities. Whether you are a business professional, researcher, or student, GizAI provides a user-friendly interface to leverage the power of AI for your specific needs.

Tableau Augmented Analytics
Tableau Augmented Analytics is a class of analytics powered by artificial intelligence (AI) and machine learning (ML) that expands a human’s ability to interact with data at a contextual level. It uses AI to make analytics accessible so that more people can confidently explore and interact with data to drive meaningful decisions. From automated modeling to guided natural language queries, Tableau's augmented analytics capabilities are powerful and trusted to help organizations leverage their growing amount of data and empower a wider business audience to discover insights.

Loata
Loata is an AI-powered platform that serves as a learning orchestrator for adaptive text analyses. It allows users to store their notes and documents in the cloud, which are then ingested and transformed into knowledge bases. The platform features smart AI agents powered by LLMs to provide intelligent answers based on the content. With end-to-end encryption and controlled ingestion, Loata ensures the security and privacy of user data. Users can choose from different subscription plans to access varying levels of storage and query capacity, making it suitable for individuals and professionals alike.

Neuwo
Neuwo is a leading contextual AI engine for content classification and automated tagging. It advocates that organizations of any size should have access to cutting-edge yet cost-effective contextual AI technology for meaningful automated content categorization and customization. The platform enables users to transition seamlessly from Oracle Grapeshot to Neuwo, offering advanced AI-driven algorithms for more precise targeting and increased engagement. Neuwo's technology ensures reaching the right audience at the right time, without the need for contracts. The platform enriches valuable data through intelligent content processing, brand safety, and suitability, and content activation, adding value to digital properties and businesses.

AI PESTEL Analysis Generator
The AI PESTEL Analysis Generator is a powerful tool designed to help organizations understand and evaluate external macro-environmental factors that can impact their business operations. By utilizing artificial intelligence technology, this tool instantly generates a comprehensive PESTEL Analysis based on the company's description. Users can easily edit and download the analysis as an image, enabling them to develop strategic plans to adapt and succeed in the marketplace. The tool simplifies the process of conducting a PESTEL analysis, providing valuable insights for decision-making and planning.

Dust
Dust is a customizable and secure AI assistant platform that helps businesses amplify their team's potential. It allows users to deploy the best Large Language Models to their company, connect Dust to their team's data, and empower their teams with assistants tailored to their specific needs. Dust is exceptionally modular and adaptable, tailoring to unique requirements and continuously evolving to meet changing needs. It supports multiple sources of data and models, including proprietary and open-source models from OpenAI, Anthropic, and Mistral. Dust also helps businesses identify their most creative and driven team members and share their experience with AI throughout the company. It promotes collaboration with shared conversations, @mentions in discussions, and Slackbot integration. Dust prioritizes security and data privacy, ensuring that data remains private and that enterprise-grade security measures are in place to manage data access policies.

Trill
Trill is an AI-powered research assistant designed to streamline the user research process. It helps users move from interviews to insights quickly by providing relevant insights and observations based on project objectives. With features like instant themes and categories, organizing findings, and a user-friendly editor, Trill aims to simplify and accelerate the research analysis process. Currently in beta, Trill offers a free trial for users to experience its capabilities and provide feedback for further improvements.

Orbital Insight GO Platform
Orbital Insight is a leading geospatial data analytics platform that provides users with the ability to query the world with three basic parameters: WHAT type of activity? WHERE on earth? WHEN? The platform automates the most difficult steps of deriving insights, allowing you to answer many challenging geospatial questions. Orbital Insight's GO platform is designed for enterprise collaboration and transforms multiple geospatial data sources to accelerate and streamline team member's research, reporting, due diligence, and more.
For similar tasks

BenevolentAI
BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

Valo
Valo is a company that uses AI-driven technology to transform the discovery and development of life-changing medicines. They combine machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. Valo's team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers are dedicated to advancing the combined power of technology and patient data.

NVIDIA
NVIDIA is a world leader in artificial intelligence computing. The company's products and services are used by businesses and governments around the world to develop and deploy AI applications. NVIDIA's AI platform includes hardware, software, and tools that make it easy to build and train AI models. The company also offers a range of cloud-based AI services that make it easy to deploy and manage AI applications. NVIDIA's AI platform is used in a wide variety of industries, including healthcare, manufacturing, retail, and transportation. The company's AI technology is helping to improve the efficiency and accuracy of a wide range of tasks, from medical diagnosis to product design.

XtalPi
XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.
For similar jobs

JADBio
JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health. The platform is trusted by partners in precision health and medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

Cradle
Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

PubCompare
PubCompare is a powerful AI-powered tool that helps scientists search, compare, and evaluate experimental protocols. With over 40 million protocols in its database, PubCompare is the largest repository of trusted experimental protocols. PubCompare's AI-powered search features allow users to find similar protocols, highlight critical steps, and evaluate the reproducibility of protocols based on in-protocol citations. PubCompare is available from any computer and requires no download.

Insitro
Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Deep Genomics
Deep Genomics is a company that uses artificial intelligence (AI) to develop RNA therapies for genetic diseases. The company's AI platform is designed to identify novel targets and evaluate thousands of possibilities to identify the best therapeutic candidates. Deep Genomics is currently developing BigRNA+, which will expand the number of mechanisms and genetic variants the company can pursue.

BenevolentAI
BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

XtalPi
XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Iambic Therapeutics
Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Tempus
Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Bionl
Bionl is a no-code bioinformatics platform designed to streamline biomedical research for researchers and scientists. It offers a full workspace with features such as bioinformatics pipelines customization, GenAI for data analysis, AI-powered literature search, PDF analysis, and access to public datasets. Bionl aims to automate cloud, file system, data, and workflow management for efficient and precise analyses. The platform caters to Pharma and Biotech companies, academic researchers, and bioinformatics CROs, providing powerful tools for genetic analysis and speeding up research processes.

Genie TechBio
Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

HoloEye.AI
HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

Mapmygenome
Mapmygenome is an AI-powered platform that offers DNA testing products for health, fitness, and beauty. It provides personalized insights based on genetic analysis to help individuals make informed decisions about their health, wellness, and lifestyle choices. With over 23 years of genomics experience and the latest sequencing technology, Mapmygenome aims to empower users to take proactive steps towards improving their overall well-being.

Chemprop
Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

Unlearn.ai
Unlearn.ai is an AI-driven platform that specializes in streamlining clinical trials through the use of AI-generated digital twins of patients. By leveraging digital twin technology and disease-specific ML models, Unlearn.ai enables researchers to design and run more efficient and impactful clinical trials across various therapeutic areas. The platform offers solutions to accelerate trial timelines, facilitate faster decision-making, and optimize trial design, ultimately enhancing trial efficiency, insights, and impact.

Eight Sleep
Eight Sleep is an intelligent bed cooling system that offers exceptional sleep experiences by actively adjusting temperature, elevating the body, and playing integrated soundscapes to improve sleep quality. The Pod works with any mattress to enhance sleep based on individual sleep stages, biometrics, and environment. It provides fully immersive cooling and heating comfort, elevation through an intelligent adjustable base, and integrated surround sound for a personalized sleep environment. The application is clinically proven to deliver real results, including faster sleep onset, more deep sleep, reduced snoring, and fewer night wake-ups. Backed by industry leaders and over 50 clinical studies, Eight Sleep is committed to optimizing rest for peak health and performance.

Woebot Health
Woebot Health is a chat-based AI wellness tool that aims to make mental health support radically accessible. Founded in 2017 by clinical research psychologist Dr. Alison Darcy, Woebot Health focuses on providing empathetic and rigorous mental health care through supportive relationships. The tool offers personalized services to improve mental health outcomes and is designed to adapt to the changing needs of individuals and organizations.

Suki AI
Suki AI is an AI-powered healthcare assistant that offers ambient documentation, clinical reasoning, assisted coding, and compliance solutions for clinicians. It provides a robust SDK and suite of APIs for integrating AI capabilities into healthcare applications. Suki aims to reduce the burden of documentation, allowing clinicians to focus on patient care. The platform is fully integrated with major enterprise EHR systems and ensures safe, clinician-reviewed documentation. Suki has a high adoption rate and delivers proven ROI by increasing coding accuracy and clinician efficiency.

PMcardio
PMcardio is an AI-powered platform that offers accurate and rapid diagnosis of cardiovascular diseases through ECG interpretation. It provides healthcare professionals with advanced AI technology to detect conditions such as acute ST-elevation myocardial infarction (STEMI) and reduced Left Ventricular Ejection Fraction (LVEF) within seconds. PMcardio aims to streamline clinical decision-making, enhance diagnostic accuracy, and improve patient care by leveraging AI algorithms trained on millions of patient outcomes. The platform is designed to ensure standardized ECG reports, facilitate care coordination, and meet the highest standards of quality and security in healthcare settings.

Glass Health
Glass Health is an AI-powered clinical decision support platform that empowers clinicians by providing tools to develop differential diagnoses and draft clinical plans. The platform combines cutting-edge AI technology with evidence-based medical knowledge to streamline diagnostic decisions and optimize clinician workflows. Glass Health's mission is to leverage technology to enhance the practice of medicine, increase diagnostic accuracy, implement evidence-based medicine, promote health equity, and improve patient outcomes globally. The platform is built by clinicians, for clinicians, with a deep commitment to safety, ethics, and alignment.

Tempus
Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Oncora Medical
Oncora Medical is a healthcare technology company that provides software and data solutions to oncologists and cancer centers. Their products are designed to improve patient care, reduce clinician burnout, and accelerate clinical discoveries. Oncora's flagship product, Oncora Patient Care, is a modern, intelligent user interface for oncologists that simplifies workflow, reduces documentation burden, and optimizes treatment decision making. Oncora Analytics is an adaptive visual and backend software platform for regulatory-grade real world data analytics. Oncora Registry is a platform to capture and report quality data, treatment data, and outcomes data in the oncology space.

CBIIT
The National Cancer Institute's Center for Biomedical Informatics and Information Technology (CBIIT) provides a comprehensive suite of tools, resources, and training to support cancer data science research. These resources include data repositories, analytical tools, data standards, and training materials. CBIIT also develops and maintains the NCI Thesaurus, a comprehensive vocabulary of cancer-related terms, and the Cancer Data Standards Registry and Repository (caDSR), a repository of cancer data standards. CBIIT's mission is to accelerate the pace of cancer research by providing researchers with the tools and resources they need to access, analyze, and share cancer data.

Modality.AI
Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.